News and Analysis
Innovation, Technology, and IP News
Feed tagged as "pharmaceuticals":
We are proud to announce that tomorrow marks the release of the fourth edition of our ANDA Litigation Intelligence Report. This year's report... Read More »
In the intricate world of pharmaceuticals, where innovation meets regulation, ANDA litigation stands as a pivotal battleground... Read More »
In the realm of pharmaceuticals, the approval process for generic and brand-name drugs holds significant importance. The Hatch-Waxman Act, ... Read More »
Abbreviated New Drug Application (ANDA) litigation stands at the crossroads of pharmaceutical innovation and legal prowess. As generic... Read More »
In the world of pharmaceuticals, access to affordable generic drugs is crucial for ensuring cost-effective healthcare solutions. The Drug... Read More »
The landscape of patent litigation is ever-evolving, and the first half of 2023 has been no exception. The dynamics of patent litigation are... Read More »
Written by: Rhett D. Ramsey & Michael L. Fuller
In Sanofi-Aventis Deutschland GmbH v. Mylan Pharm. Inc., Case No. 2021-1981, the... Read More »
Written by: Brianne M. Kingery & Eric Furman, Ph.D.
On June 6, 2023, Merck & Co. filed a lawsuit against the U.S. government... Read More »
The Oncomouse patent stands as a remarkable milestone in the field of biotechnology patents, revolutionizing the way we approach... Read More »
Written by:Nima Zargari, Ph.D. & Joseph Mallon, Ph.D.
On April 26, 2023, the European Commission proposed a pharmaceutical law... Read More »
SANOFI-AVENTIS DEUTSCHLAND GMBH V. MYLAN PHARMACEUTICALS INC.
Before Reyna, Mayer, and Cunningham. Appeal from Patent Trial and Appeal... Read More »
Written by: Jeremy Anapol
UNITED CANNABIS CORPORATION V. PURE HEMP COLLECTIVE INC.
Before Lourie, Cunningham, and Stark... Read More »
Written by: Matthew S. Whitehead & Douglas B. Wentzel
UCB, INC. v. ACTAVIS LABORATORIES UT, INC.
Before Moore, Chen, and... Read More »
Written by: Ari Feinstein & Agnes Juang, Ph.D.
On March 29, 2023, the Solicitor General of the United States asked the Supreme... Read More »
Written by: Brandon D. Hupka & Hans L. Mayer
REGENTS OF THE UNIVERSITY OF MINNESOTA V. GILEAD SCIENCES, INC.
Before... Read More »
Written by: Tyler S. Cox & Kendall Loebbaka
JAZZ PHARMACEUTICALS, INC. v. AVADEL CNS PHARMACEUTICALS, LLC
Before Lourie... Read More »
Written by: Mark Rubinshtein, Ph.D.
Biopharmaceutical New Technologies (BioNTech), the global immunotherapy company based in... Read More »
Written by: Kendall Loebbaka & Cesar A. Estrada
GENENTECH, INC. V. SANDOZ INC.
Before Newman, Lourie, and Prost. Appeal... Read More »
In late August, we published our third annual ANDA Litigation Intelligence Report. We evaluated the stakeholders for Hatch-Waxman cases filed... Read More »
In late August, we published our third annual ANDA Litigation Intelligence Report, covering important statistics and evaluating all stakeholders in ... Read More »